Givaudan SA (FRA:GIN)
Germany · Delayed Price · Currency is EUR | Market Cap | 32.72B -3.0% |
| Revenue (ttm) | 8.02B -1.8% |
| Net Income | 1.03B -12.8% |
| EPS | 111.26 -13.0% |
| Shares Out | n/a |
| PE Ratio | 31.66 |
| Forward PE | 26.31 |
| Dividend | 79.01 (2.32%) |
| Ex-Dividend Date | Mar 23, 2026 |
| Volume | 1 |
| Open | 3,512.00 |
| Previous Close | 3,515.00 |
| Day's Range | 3,512.00 - 3,535.00 |
| 52-Week Range | 2,827.00 - 3,876.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 27, 2027 |
About Givaudan
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, and alcoholic drinks; dairy and cheese products, in... [Read more]
Financial Performance
In 2025, Givaudan's revenue was 7.47 billion, an increase of 0.81% compared to the previous year's 7.41 billion. Earnings were 1.07 billion, a decrease of -1.74%.
Financial numbers in CHF Financial StatementsNews
India investigates fragrance giants over price collusion, document shows
Global fragrance makers Givaudan , Firmenich and International Flavors & Fragrances face a second antitrust investigation by Indian authorities, according to a regulatory document seen by Reuters.
Givaudan price target raised to CHF 3,650 from CHF 3,300 at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte raised the firm’s price target on Givaudan (GVDNY) to CHF 3,650 from CHF 3,300 and keeps a Buy rating on the shares. Published first on…
Givaudan Earnings Call Transcript: Q2 2026
Solid H1 2026 results with 3.6% like-for-like sales growth and strong Fragrance & Beauty momentum, despite non-recurring costs and currency headwinds. Sequential improvement in Taste & Wellbeing and robust project pipeline support confidence in meeting 2030 targets.
Givaudan Earnings release: Q2 2026
Givaudan released its Q2 2026 earnings on July 23, 2026, summarizing the period's financial results.
Givaudan Slides: Q2 2026
Givaudan has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 23, 2026.
Givaudan Quarterly report: Q2 2026
Givaudan has published its Q2 2026 quarterly earnings report on July 23, 2026.
Givaudan H1 Profit, Sales Down; Backs LFL Sales Growth View Ahead
(RTTNews) - Givaudan AG (GVDBF.PK), a Swiss manufacturer of flavors, fragrances, and cosmetic ingredients, reported Thursday a decline in net income in its first half of fiscal 2026, with weak net sal...
Givaudan's organic sales top market estimates on fragrance strength
Swiss fragrance and flavour maker Givaudan reported second-quarter organic sales that beat market estimates on Thursday, driven by stronger-than-expected growth in its fragrance division, while its fl...
Givaudan initiated with an Underperform at Bernstein
Bernstein initiated coverage of Givaudan (GVDNY) with an Underperform rating and CHF 2,886 price target The firm says that after 15 years of market outperformance versus chemicals, sector rotation and...
Givaudan price target raised to CHF 3,300 from CHF 3,100 at Barclays
Barclays analyst Alex Sloane raised the firm’s price target on Givaudan (GVDNY) to CHF 3,300 from CHF 3,100 and keeps an Equal Weight rating on the shares. The company’s second…
Givaudan price target raised to CHF 2,900 from CHF 2,875 at Morgan Stanley
Morgan Stanley analyst Lisa De Neve raised the firm’s price target on Givaudan (GVDNY) to CHF 2,900 from CHF 2,875 and keeps an Equal Weight rating on the shares. Published…
Givaudan upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte upgraded Givaudan (GVDNY) to Buy from Hold with a price target of CHF 3,300, up from CHF 3,000. The firm says the company is seeing…
Givaudan upgraded to Buy from Sell at Goldman Sachs
Goldman Sachs upgraded Givaudan (GVDNY) to Buy from Sell with a price target of CHF 3,500, up from CHF 2,900. The firm made seven rating changes in European chemicals, “positioning…
Givaudan downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded Givaudan (GVDNY) to Hold from Buy with a price target of CHF 3,000, down from CHF 3,600. The firm cites the stock’s premium multiple for the downgrade.
PepsiCo, Givaudan, Smurfit Westrock and Statkraft sign renewable energy deal
PepsiCo (PEP), Givaudan (GVDNY), Smurfit WestRock (SW) and Statkraft have announced a 10-year Virtual Power Purchase Agreement, or VPPA, with an underlying wind asset in Spain which is undergoing repo...
Givaudan price target raised to CHF 2,920 from CHF 2,915 at Berenberg
Berenberg raised the firm’s price target on Givaudan (GVDNY) to CHF 2,920 from CHF 2,915 and keeps a Hold rating on the shares.
Givaudan upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Givaudan (GVDNY) to Overweight from Neutral with an unchanged price target of CHF 3,600. The firm believes the stock’s de-rating and the company’s sales growth “may have troughed.”…
Givaudan beats sales estimates as fragrance demand lifts shares
Swiss fragrance and flavour maker Givaudan reported stronger-than-expected first-quarter sales growth, supported by robust demand in its fragrance and consumer products segment. The company said its L...
Givaudan Earnings release: Q1 2026
Givaudan released its Q1 2026 earnings on April 14, 2026, summarizing the period's financial results.
Givaudan Slides: Investor presentation
Givaudan has posted slides in relation to its latest quarterly earnings report, which was published on April 9, 2026.
Givaudan downgraded to Hold from Buy at Berenberg
Berenberg downgraded Givaudan (GVDNY) to Hold from Buy with a price target of CHF 2,915, down from CHF 3,580. The firm is concerned the company’s organic sales growth could continue…
Givaudan downgraded to Equal Weight from Overweight at Barclays
Barclays downgraded Givaudan (GVDNY) to Equal Weight from Overweight with a price target of CHF 3,050, down from CHF 3,550. The firm says a “renewed spike” in costs from the…
Givaudan downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Givaudan (GVDNY) to Hold from Buy with a price target of CHF 3,000, down from CHF 3,750. The firm adjusted ratings in the European chemicals and ingredients…
Givaudan price target lowered to CHF 2,875 from CHF 3,000 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Givaudan (GVDNY) to CHF 2,875 from CHF 3,000 and keeps an Equal Weight rating on the shares.
Givaudan price target lowered to CHF 3,150 from CHF 3,350 at Citi
Citi analyst Ranulf Orr lowered the firm’s price target on Givaudan (GVDNY) to CHF 3,150 from CHF 3,350 and keeps a Neutral rating on the shares.